Robert Best to Prenatal Diagnosis
This is a "connection" page, showing publications Robert Best has written about Prenatal Diagnosis.
Connection Strength
0.569
-
Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016 10; 18(10):1056-65.
Score: 0.127
-
Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States? Genet Med. 2015 Nov; 17(11):897-900.
Score: 0.116
-
Attitudes toward presymptomatic testing and prenatal diagnosis for adrenoleukodystrophy among affected families. Am J Med Genet. 1991 Dec 01; 41(3):295-300.
Score: 0.092
-
Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023 02; 25(2):100336.
Score: 0.049
-
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020. J Med Screen. 2021 12; 28(4):405-410.
Score: 0.045
-
Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
Score: 0.040
-
Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020 03; 22(3):462-474.
Score: 0.040
-
Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations. Genet Med. 2019 10; 21(10):2285-2292.
Score: 0.038
-
Ethical issues in genetic counseling: a comparison of M.S. counselor and medical geneticist perspectives. J Genet Couns. 1992 Mar; 1(1):19-30.
Score: 0.023